SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 157.90 |
| Enterprise Value ($M) | 120.00 |
| Book Value ($M) | 95.51 |
| Book Value / Share | 0.71 |
| Price / Book | 1.65 |
| NCAV ($M) | 89.64 |
| NCAV / Share | 0.66 |
| Price / NCAV | 1.76 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.07 |
| Return on Assets (ROA) | -0.62 |
| Return on Equity (ROE) | -0.73 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.90 |
| Current Ratio | 9.90 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 102.60 |
| Assets | 108.47 |
| Liabilities | 12.96 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Biotechnology Value Fund L P | |||
| 13G | Medicxi IV LP | |||
| 13G | TCG Crossover GP II, LLC | |||
| 13G | Foresite Capital Fund VI LP | |||
| 13D/A | Column Group Ii, Lp | |||
| 13G | Deep Track Capital, LP | |||
| 13G/A | Price T Rowe Associates Inc /md/ | 0.50 | -94.85 | |
| 13G/A | Vanguard Group Inc | 9.04 | 0.00 | |
| 13G/A | Fmr Llc | 15.00 | 36.22 | |
| 13G/A | Redmile Group, LLC | 9.90 | 2.64 | |
| 13G/A | Perceptive Advisors Llc | 6.20 | 18.96 | |
| 13G/A | BlackRock, Inc. | 7.10 | 28.87 | |
| 13G/A | State Street Corp | 4.23 | -25.05 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 189,578 | 640,253 | 29.61 | |
| 208,602 | 2,661,127 | 7.84 | |
| 79,337 | 601,109 | 13.20 | |
| 102,140 | 903,175 | 11.31 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PWUP – PowerUp Acquisition Corp. | QTTB – Q32 Bio Inc. |
| RANI – Rani Therapeutics Holdings, Inc. | RCKT – Rocket Pharmaceuticals, Inc. |
| RLAY – Relay Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io